These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2942440)

  • 21. [Polycythemia vera: the disadvantages of overproduction].
    Aumiller J
    MMW Fortschr Med; 2015 Apr; 157(8):18-20. PubMed ID: 26012664
    [No Abstract]   [Full Text] [Related]  

  • 22. 125I fibrinogen turnover in polycythaemia: the effect of phlebotomy.
    Boughton BJ; Dallinger KJ
    Br J Haematol; 1983 Jan; 53(1):97-102. PubMed ID: 6848130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of rheopolyglucin after bloodletting in patients with polycythemia vera].
    Al'nikov GP; Podgurskaia RA; Chistiakova VG
    Ter Arkh; 1977; 49(8):85-7. PubMed ID: 929398
    [No Abstract]   [Full Text] [Related]  

  • 24. [Large volume, isovolemic erythrocytapheresis in treatment of polycythemia vera. Effect of massive iron depletion of proliferation behavior of erythroid precursor cells (BFU-E)].
    Liersch T; Vehmeyer K; Kaboth U
    Med Klin (Munich); 1995 Jul; 90(7):390-7. PubMed ID: 7675003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of polycythaemia vera with reinfusion of autologous blood plasma obtained by phlebotomy.
    Stefanović S; Radotić M; Dukić M; Ristić M; Banićević B; Jancić MS; Maslovarić S
    Haematologia (Budap); 1974; 8(1-4):473-6. PubMed ID: 4461432
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunological analysis of the content of erythrocyte chalone factors in the blood in certain types of pathology].
    Neustroev GV; Melikian AL; Kovaleva LG; Blazhko OB
    Gematol Transfuziol; 1985 Sep; 30(9):21-6. PubMed ID: 2932362
    [No Abstract]   [Full Text] [Related]  

  • 27. [The treatment of erythremia].
    Demidova AV
    Ter Arkh; 1992; 64(7):116-23. PubMed ID: 1440358
    [No Abstract]   [Full Text] [Related]  

  • 28. [Role of erythrocyte chalone in regulating erythropoiesis].
    Neustroev GV
    Usp Fiziol Nauk; 1981; 12(2):131-48. PubMed ID: 6267838
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myelofibrosis in polycythemia vera following 15 years of phlebotomy].
    Yonemitsu H; Kondo H; Okuda K; Endo N; Yamaguchi K
    Rinsho Ketsueki; 1983 Aug; 24(8):1092-7. PubMed ID: 6645077
    [No Abstract]   [Full Text] [Related]  

  • 30. Chromosomal aberrations in polycythemia vera.
    Modan B; Padeh B; Kallner H; Akstein E; Meytes D; Czerniak P; Ramot B; Pinkhas J; Modan M
    Blood; 1970 Jan; 35(1):28-38. PubMed ID: 5412672
    [No Abstract]   [Full Text] [Related]  

  • 31. The treatment of polycythemia vera.
    Wasserman LR
    Semin Hematol; 1976 Jan; 13(1):57-78. PubMed ID: 1251223
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biological activity of erythrocytic chalone in erythremia].
    Neustroev GV; Petrov KIa
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):57-8. PubMed ID: 155249
    [No Abstract]   [Full Text] [Related]  

  • 33. Polycythemia vera in a cat with cardiac hypertrophy.
    Foster ES; Lothrop CD
    J Am Vet Med Assoc; 1988 Jun; 192(12):1736-8. PubMed ID: 2970451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elliptocytosis preceding myelofibrosis in a patient with polycythemia vera.
    Djaldetti M; Cohen A; Hart J
    Acta Haematol; 1984; 72(1):26-8. PubMed ID: 6433628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [I-131 absorption in patients with polycythemia vera and change in this index after treatment by bloodletting and with P32].
    Shishkina VV; Suslina NG; Chebotareva ED
    Med Radiol (Mosk); 1968 Apr; 13(4):50-4. PubMed ID: 5658003
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythrocytosis associated with normal blood-gas values.
    Lange RD
    Adv Intern Med; 1976; 21():309-33. PubMed ID: 3103
    [No Abstract]   [Full Text] [Related]  

  • 37. [Short and longtime adaptation mechanisms of cardiopulmonary system following bloodletting in polyglobulias of various etiology].
    Rühle KH; Konietzko N; Schlehe H; Matthys H
    Verh Dtsch Ges Inn Med; 1973; 79():896-8. PubMed ID: 4790036
    [No Abstract]   [Full Text] [Related]  

  • 38. Principia of cancer therapy. IV. Induction of hemoconcentration for phlebotomy in polycythemia vera.
    Okuyama S; Mishina H; Ito Y; Matsuzawa T
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):29-30. PubMed ID: 6678498
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of polycythemia vera].
    Stecher G; Hennemann HH
    Minerva Med; 1969 Oct; 60(87):4351-3. PubMed ID: 5354514
    [No Abstract]   [Full Text] [Related]  

  • 40. Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia.
    Haq AU
    Am J Hematol; 1990 Oct; 35(2):110-3. PubMed ID: 2399902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.